Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Treatment of cutaneous melanoma: current approaches and future prospects.

Algazi AP, Soon CW, Daud AI.

Cancer Manag Res. 2010 Aug 17;2:197-211. doi: 10.2147/CMR.S6073.

2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
3.

Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach.

Davar D, Tarhini AA, Kirkwood JM.

Clin Dermatol. 2013 May-Jun;31(3):237-50. doi: 10.1016/j.clindermatol.2012.08.012. Review. Erratum in: Clin Dermatol. 2013 Jul-Aug;31(4):501.

4.

The role of adjuvant therapy in melanoma management.

Barth A, Morton DL.

Cancer. 1995 Jan 15;75(2 Suppl):726-34. Review.

5.

Adjuvant treatment of melanoma.

Moreno Nogueira JA, Valero Arbizu M, Pérez Temprano R.

ISRN Dermatol. 2013;2013:545631. doi: 10.1155/2013/545631. Epub 2013 Feb 17.

6.

Melanoma: adjuvant therapy and other treatment options.

Terando A, Sabel MS, Sondak VK.

Curr Treat Options Oncol. 2003 Jun;4(3):187-99. Review.

PMID:
12718796
7.

Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.

Minutilli E, Feliciani C.

Tumori. 2012 Mar-Apr;98(2):185-90. doi: 10.1700/1088.11928. Review.

PMID:
22677983
8.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
9.

Recent advances in the care of the patient with malignant melanoma.

Reintgen D, Balch CM, Kirkwood J, Ross M.

Ann Surg. 1997 Jan;225(1):1-14. Review.

10.

Current concepts in the management of patients with melanoma.

Lang PG.

Am J Clin Dermatol. 2002;3(6):401-26. Review.

PMID:
12113649
11.

Adjuvant therapy of malignant melanoma.

Dickler MN, Coit DG, Meyers ML.

Surg Oncol Clin N Am. 1997 Oct;6(4):793-812. Review.

PMID:
9309094
12.

Treatment of malignant melanoma.

Durán García E, Santolaya R, Requena T.

Ann Pharmacother. 1999 Jun;33(6):730-8. Review.

PMID:
10410188
13.

Melanoma. A multidisciplinary approach for the general surgeon.

Reeves ME, Coit DG.

Surg Clin North Am. 2000 Apr;80(2):581-601. Review.

PMID:
10836008
14.

Treatment of metastatic malignant melanoma.

Atallah E, Flaherty L.

Curr Treat Options Oncol. 2005 May;6(3):185-93. Review.

PMID:
15869730
15.
16.

Adjuvant therapy for high-risk primary and resected metastatic melanoma.

Hersey P.

Intern Med J. 2003 Jan-Feb;33(1-2):33-43. Review.

PMID:
12534876
17.

Neoadjuvant therapy for high-risk bulky regional melanoma.

Tarhini AA, Pahuja S, Kirkwood JM.

J Surg Oncol. 2011 Sep;104(4):386-90. doi: 10.1002/jso.21882. Review.

PMID:
21858833
18.

Adjuvant irradiation for axillary metastases from malignant melanoma.

Ballo MT, Strom EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, Lee JE, Gershenwald JE, Ross MI.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):964-72.

PMID:
11958890
19.

Novel immunotherapeutic agents and small molecule antagonists of signalling kinases for the treatment of metastatic melanoma.

Natarajan N, Telang S, Miller D, Chesney J.

Drugs. 2011 Jul 9;71(10):1233-50. doi: 10.2165/11591380-000000000-00000. Review.

PMID:
21770473
20.

European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma.

Eggermont AM, Gore M.

Semin Oncol. 2002 Aug;29(4):382-8. Review.

PMID:
12170441
Items per page

Supplemental Content

Write to the Help Desk